Robotic versus Open Hepatic Arterial Infusion Pump Placement for Unresectable Intrahepatic Cholangiocarcinoma

B. Ten Haaft(University of Amsterdam), Rutger‐Jan Swijnenburg(Amsterdam University Medical Centers), Heinz‐Josef Klümpen(University Medical Center Groningen), Stijn Franssen(Erasmus MC Cancer Institute), Jeroen Hagendoorn(Utrecht University), J. Erdmann(Amsterdam University Medical Centers), R. van Dorst(University Medical Center Utrecht), Bas Groot Koerkamp
HPB
January 1, 2023
10.1016/j.hpb.2023.07.062
Cited by 1

Related Papers

Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2023|1k
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
|The Lancet Oncology|2016|914
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial
|˜The œLancet. Gastroenterology & hepatology|2019|597
Futibatinib for <i>FGFR2</i> -Rearranged Intrahepatic Cholangiocarcinoma
|New England Journal of Medicine|2023|530